Pfizer Ltd's board has approved a five-year marketing and supply agreement with Mylan Pharmaceuticals for the brands Ativan and Pacitane, t...

Meenakshi Nevatia, a seasoned executive with nearly 30 years of business leadership and consulting experience, was with companies such as M...

Pharmaceutical major Pfizer today appointed S Sridhar as its new Managing Director (MD) with immediate effect for a period of five years.

Top multinational drug makers Pfizer and GlaxoSmithKline have initiated major reshuffle of senior leadership teams in India in face of comp...

Shares of Pfizer rose by over 3 per cent as pharmaceuticals giant Pfizer Inc will acquire Hospira Inc, a leading provider of injectable dru...

Britain's AstraZeneca on Monday rejected a sweetened 55-pounds-a-share offer from Pfizer.

SES, promoted by J N Gupta, former executive director at the Securities and Exchange Board of India, said the deal is skewed in favour of P...

Pfizer East India will acquire 29 per cent and 31 per cent in the company from the Netherlands and Panama units, respectively.

Pfizer India on Saturday said the company will merge its Indian subsidiary Wyeth Ltd with itself.

Pfizer India today said the respective Boards of Directors of Pfizer Ltd and Wyeth Ltd will meet on November 23 to consider the merger prop...

In a relief to pharma major Pfizer, the Intellectual Property Appellate Board here has set aside the revocation of the patent of the compan...

Net sales of the company stood at Rs 229.78 crore for the quarter under consideration against Rs 251.88 crore for the year-ago period.

Drug firm Pfizer today posted net profit of Rs 52.28 crore for the second quarter ended September 30.

Drug maker Pfizer Ltd today said the company's shareholders have approved the sale of its animal health division to its subsidiary, Pfizer ...

Pfizer Ltd said its board has approved setting up of a new subsidiary as part of plans to hive off the company's animal health business.

Pfizer India will hire an additional 200 people in the next few months and will continue to increase its headcount because it sees minimal ...

Financial institutions led by the LIC are objecting to US pharma major Pfizer Inc's open offer to increase stake in its Indian arm from 41%...